BRCA2 and neoplasm: BRCAness describes tumours that possess histopathological and molecular characteristics similar to those found in patients with germ-line BRCA1 or BRCA2 gene defects, including a distinctive DNA repair defect arising from loss of Homologous Recombination (HR) and drug sensitivity effects associated with this HR defect, including exquisite PARP inhibitor sensitivity6.